4
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Urokinase Inhibitor in Human Plasma

Pages 314-321 | Received 08 Jul 1968, Accepted 30 Sep 1968, Published online: 05 Aug 2009

References

  • Bennett N. B. A method for the quantitative assay of inhibitor of plasminogen activation in human serum. Thromb. Dialh. Haemorrh. 1967; 17: 12
  • Blix S. The quantitative determination of fibrino-lytic inhibitors in plasma or serum by means of the fibrin plate. Scand. J. din. Lab. Invest. 1964; 16: 403
  • Brakman P., Astrup T. Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis. Scand. J. din. Lab. Invest. 1963; 15: 603
  • Bruce S. The effect of calcium on fibrinolysis in vitro. J. din. Path. 1964; 17: 282
  • Flute P. T. Fibrinolytic factors as demonstrated by electrophoresis of human blood. Proc. 7th Congr. Europ. Soc. Haematol. London 1959; 894, part 2, 1960
  • Hultin E., Lundblad G. Investigations on plasmin. III. On the formation of plasmin from plasminogen. Ada chem. scand. 1949; 3: 620
  • Jacobsen C. D. The antiplasmin activity of human plasma and serum and its dependence on ions. Scand. J. din. Lab. Invest. 1964; 16: 383
  • Kjeldgaard N. O., Ploug J. Urokinase, an activator of plasminogen from human urine. II. Mechanism of plasminogen activation. Biochim. biophys. Ada (Amst.) 1957; 24: 283
  • Lauritsen O. S. A caseinolytic method for measuring serum inhibitors against fibrinolysis. Scand. J. din. Lab. Invest. 1965; 17(Suppl. 86)161
  • Lauritsen O. S. Some observations on the caseinolytic properties of a purified, activator-free, porcine plasmin preparation. Scand. J. din. Lab. Invest. 1966; 18: 64
  • Lauritsen O. S. Activation of porcine plasminogen by human urokinase. Scand. J. din. Lab. Invest. 1968; 22: 239
  • Lewis J. H., Ferguson J. H. Studies on a proteolytic enzyme system of the blood. IV. Activation of profibrinolysin by serum fibrino-lysokinase. Proc. Soc. exp. Biol. Med. 1951; 78: 184
  • Lorand J., Condit E. V. Ester hydrolysis by urokinase. Biochemistry 1965; 4: 265
  • Mann R. D. Method of estimating the inhibitory effect of plasma or serum upon urokinase-activated fibrinolysis. J. din. Path. 1966; 19: 233
  • Mollertz S. Components interacting in the formation of plasminogen activator in human blood. Proc. 1st internal, confer, on thrombolysis and embolism. Basel 1954; 79
  • McNicol G. P., Gale S. B., Douglas A. S. In-vitro and in-vivo studies of a preparation of urokinase. Brit. Med. J. 1963; I: 909
  • Nilsson I. M., Krook H., Sternby N.-H., Soderberg E., Soderstrom N. Severe throm-botic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Ada med. scand. 1961; 169: 323
  • Norman P. S. Studies on the plasmin system. II. Inhibition of plasmin by serum or plasma. J. exp. Med. 1958; 108: 53
  • Paraskevas M., Nilsson I. M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand. J. din. Lab. Invest. 1962; 14: 138
  • Sherry S., Alkjaersig N., Fletcher A. P. Assay of urokinase preparations with the synthetic substrate acetyl-L-lysine methyl ester. J. Lab. din. Med. 1964; 64: 145
  • Schmitz A. Uber die Freilegung von aktivem Trypsin aus Blutplasma. Zweite Mitteilung zur Kenntnis des Plasmatrypsinsystcms. Z. physiol. Chemie 1937; 250: 37
  • deWit C. D. Investigations on the inhibitors of the fibrinolytic system. Thromb. Diath, Haemorrh. 1964; 12: 105

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.